Journal of Developmental Medicine(Electronic Version)   2024, Vol. 12   Issue (4): 302-308    DOI: 10.3969/j.issn.2095-5340.2024.04.010 | 
										 
				   
				
					
						
							
								
									 | 
									
										
		  							 | 
          							
		  									  								 
		  									  							|
		  									  								 
		  									  							 | 
        						 
      						 
      					 | 
  					 
  					
    					 | 
   					 
   										
    					| Research progress on the role of oxidative stress signaling pathways in pain pathogenesis ofchronic prostatitis/chronic pelvic pain syndrome | 
  					 
  					  										
						| Zhang Qiang, Su Xuzhen, Xiang Ruijun, et al
 | 
					 
															
						(1. School of ClinicalMedicine, Gansu University of Chinese Medicine, Gansu, Lanzhou 730030, China; 2. Department of Urology, the 940 Hospital of Joint Logistics Support Force of Chinese PLA, Gansu, Lanzhou 730050, China)
  | 
					 
										
						 | 
					 
				 
				
				
					
						
							
								
									
										
											
                        					 
												
													
													    | 
													    	
														 | 
													 
																										
													
														
															
													
													    
													     		                            						                            																	    Abstract  【Abstract】Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) is a common urological disease. 
In the research progress of CP/CPPS treatment, it has been found that the regulation of oxidative stress andinflammation response through nuclear factor kappa-B (NF-κB), nuclear factor erythroid-2 related factor2 (Nrf2), mitogen-activated protein kinase (MAPK) and other signaling pathways can reduce CP/CPPS 
symptoms. In recent years, it has been found that the regulation of forkhead box O (FOXO), silent informationregulator 1(Sirt1), extracellular signal-regulated kinase(Erk), ras homolog gene family member A(RhoA)/Rho-associated protein kinase 1(ROCK1) and other signaling pathways can relieve prostatic inflammationand pelvic pain, providing a new target for CP/CPPS treatment. 
																										     | 
														 
														
														
															| 
															    																	Received: 03 February 2023
																	    
															    															    															    																	Published: 31 July 2024
															    															 | 
														 
														 																											    																														 
															 | 
																															
															
													    	
															 | 
																
															
														 
														
													 
													
												 
												
												
												
											
											 
											
											 
										 
									 | 
								 
							 
						 | 
					 
				 
			
		 |